Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Envista Holdings Corporation stock

Own Envista Holdings Corporation stock in just a few minutes.

Envista Holdings Corporation is a medical instruments & supplies business based in the US. Envista Holdings Corporation shares (NVST) are listed on the NYSE and all prices are listed in US Dollars. Envista Holdings Corporation employs 12,400 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Envista Holdings Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NVST – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Envista Holdings Corporation share price

Use our graph to track the performance of NVST stocks over time.

Envista Holdings Corporation shares at a glance

Information last updated 2021-04-21.
52-week range$14.73 - $43.88
50-day moving average $40.87
200-day moving average $34.40
Wall St. target price$45.30
PE ratio 27.1214
Dividend yield N/A (0%)
Earnings per share (TTM) $1.60

Buy Envista Holdings Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Envista Holdings Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Envista Holdings Corporation under- or over-valued?

Valuing Envista Holdings Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Envista Holdings Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Envista Holdings Corporation's P/E ratio

Envista Holdings Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, Envista Holdings Corporation shares trade at around 27x recent earnings.

That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).

Envista Holdings Corporation's EBITDA

Envista Holdings Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $345.4 million.

The EBITDA is a measure of a Envista Holdings Corporation's overall financial performance and is widely used to measure a its profitability.

Envista Holdings Corporation financials

Revenue TTM $2.3 billion
Operating margin TTM 9.33%
Gross profit TTM $1.2 billion
Return on assets TTM 2.04%
Return on equity TTM 0.92%
Profit margin 1.46%
Book value $22.13
Market capitalisation $7 billion

TTM: trailing 12 months

Shorting Envista Holdings Corporation shares

There are currently 9.1 million Envista Holdings Corporation shares held short by investors – that's known as Envista Holdings Corporation's "short interest". This figure is 1.5% up from 9.0 million last month.

There are a few different ways that this level of interest in shorting Envista Holdings Corporation shares can be evaluated.

Envista Holdings Corporation's "short interest ratio" (SIR)

Envista Holdings Corporation's "short interest ratio" (SIR) is the quantity of Envista Holdings Corporation shares currently shorted divided by the average quantity of Envista Holdings Corporation shares traded daily (recently around 1.1 million). Envista Holdings Corporation's SIR currently stands at 8.06. In other words for every 100,000 Envista Holdings Corporation shares traded daily on the market, roughly 8060 shares are currently held short.

However Envista Holdings Corporation's short interest can also be evaluated against the total number of Envista Holdings Corporation shares, or, against the total number of tradable Envista Holdings Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Envista Holdings Corporation's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Envista Holdings Corporation shares in existence, roughly 60 shares are currently held short) or 0.071% of the tradable shares (for every 100,000 tradable Envista Holdings Corporation shares, roughly 71 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Envista Holdings Corporation.

Find out more about how you can short Envista Holdings Corporation stock.

Envista Holdings Corporation share dividends

We're not expecting Envista Holdings Corporation to pay a dividend over the next 12 months.

Envista Holdings Corporation overview

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Kerr, Metrex, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site